Skip to main content
Have a personal or library account? Click to login
Decoding the latent molecular interactions between aspartame and hepatocellular carcinoma: A multi-omics and machine learning integration Cover

Decoding the latent molecular interactions between aspartame and hepatocellular carcinoma: A multi-omics and machine learning integration

By: ,   and    
Open Access
|Apr 2026

Abstract

Objective

To understand the latent molecular interactions between aspartame and hepatocellular carcinoma (HCC), this study analyzes the critical functions of genes involved in redox imbalance that may facilitate malignancy.

Materials and Methods

We employed a hybrid computational strategy – combining transcriptomic differential expression, weighted gene co-expression network analysis, and an ensemble of 12 machine learning techniques – to isolate central oxidative stress (OS) genes involved in the aspartame-HCC axis. The binding capacities of aspartame toward identified target molecules were subsequently authenticated through network toxicology and molecular docking analyses.

Results

In total, 42 shared targets were discovered within the aspartame-HCC axis. Utilizing machine learning, four pivotal OS-related genes – specifically rho family guanosine triphosphatase (GTPase) 3 (RND3), glutathione S-transferase zeta 1 (GSTZ1), aurora kinase A (AURKA), and ADP-ribosylation factor 1 (ARF1) – were prioritized. Among these, ARF1 and AURKA showed significant overexpression, whereas GSTZ1 and RND3 exhibited substantial downregulation in hepatic malignancy (P < 0.001). Furthermore, the structural interactions between aspartame and these central proteins were validated via docking, revealing strong affinities with energies between −7.1 and −5.0 kcal/mol.

Conclusion

This study highlights that aspartame may be associated with HCC progression via potential interactions with specific OS genes and the associated signaling pathways.

Language: English
Page range: 68 - 80
Submitted on: Nov 25, 2025
Accepted on: Apr 17, 2026
Published on: Apr 18, 2026
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2026 Zhou An, Xianhua Wang, Yuyun Jia, published by Hirszfeld Institute of Immunology and Experimental Therapy
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.